Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Injected Directly into the Brain for Alzheimer’s Disease in Podium Presentation at the ISCT 2025 Scie
-
Microbix’s Clot-Buster Drug Project Advances
-
Update to Zijin Put Option and Exclusivity Arrangements
-
Asante Projects Transformative Growth in Updated Five-Year Outlook: 500,000+ oz Annual Gold Production by 2028, >$2 Billion in Free Cash Flow, Increased Mineral Reserves
-
Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights
-
Mobilicom’s Cybersecure Drone and Robotics Solutions to Feature at Key U.S. Defense & Autonomy Industry Events
-
Goldco Honored With Bronze Stevie® Award In 2025 American Business Awards®
-
Be the Best LI and Lacrosse Unlimited Announce Three-Year Premier Partnership
-
Sunoco LP to Acquire Parkland Corporation in Transaction Valued at $9.1 Billion
-
As Federal Collections Activity Resumes, More Than One in Five Federal Student Loan Borrowers With a Payment Due are Seriously Delinquent
-
Kootenay Silver Reports Drill Results from Columba Project, Chihuahua, Mexico: Highs to 7,630 gpt Silver and 30.57% Combined Lead-Zinc
-
MTY Food Group Inc. Announces Results from 2025 Annual General Meeting
-
Osisko Metals Intersects 323 Metres Averaging 0.43% Cu at Gaspé Project
-
Amrop Rosin Announces Merger in Canada
-
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting
-
IsoEnergy Marks Milestone as Trading Begins on the NYSE American Under "ISOU"
-
Detailed Results From B-Series OCT with ImgAssist AI 2.0 Pivotal Trial Presented at ASBrS 2025
-
PTC518 PIVOT-HD Study Achieves Primary Endpoint
-
ARITZIA ANNOUNCES NORMAL COURSE ISSUER BID
-
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®
-
Northstar Completes Emission Reduction Alberta Construction Milestone and Receives $3.9 Million
-
Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025
-
Apollo Silver Appoints Ross McElroy as President and CEO
-
Aircastle Announces $600 million Unsecured Financing Facility
-
Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September
-
Employers face rising healthcare costs from climate risks and new forecasting tool helps them assess the impact
-
LUCA DISCOVERS MULTIPLE NEW HIGH-GRADE ORE SHOOTS AT TAHUEHUETO MINE, DURANGO, MEXICO
-
Safeguard Global Unveils Brand Evolution Focused on Expert-Led Global Expansion
-
NAPCO Security Technologies, Inc. Reports Fiscal 2025 Third Quarter Results
-
PLBY Group to Report First Quarter 2025 Financial Results on May 15, 2025
-
Welcome Home: Vivint Debuts New Brand Identity, Signaling a New Era in Smart Home
-
Tatte Bakery and Café Opens First Location in New Jersey
-
Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma
-
Local Snapshot: Half Of U.S. Small Businesses Change Strategies Amid Macro-Economic Challenges, Chase Survey Finds
-
Thoma Bravo Announces More Than $100M Strategic Growth Investment in HubSync
-
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
-
SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR MAY 2025
-
Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025
-
Nexstar Media Group Declares Quarterly Cash Dividend of $1.86 Per Share
-
DoorDash Announces Date and Time Change of First Quarter 2025 Financial Results and Conference Call
-
Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera
-
Joey Chestnut to Attempt Popcorn World Record at Rural King This Memorial Day Weekend
-
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
-
Aptose Provides Clinical Update for the Tuspetinib-based Triple Drug Frontline Therapy in Newly Diagnosed AML Patients from the Phase 1/2 TUSCANY Trial
-
Routeware Celebrates 25 Years of Transformation in Waste Management Technology
-
Elliott Fails to Address Key Investor Questions
-
Angel Oak Mortgage REIT, Inc. Reports First Quarter 2025 Financial Results
-
WESTERN MIDSTREAM ANNOUNCES APPOINTMENT OF ROBERT G. PHILLIPS AS INDEPENDENT DIRECTOR
-
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025
-
World Ovarian Cancer Coalition Leads Global Campaign to Raise Awareness of Ovarian Cancer


